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Accepted 28 December 2011AbstractObjective: To compare the costs of traditional open myomectomy (OM) with laparoscopic myomectomy (LM).
Materials and Methods: A retrospective review was conducted of the medical records of 155 women who underwent traditional open myo-
mectomy (OM) or laparoscopic myomectomy (LM) in a teaching hospital in Taiwan.
Results: The total medical service expense and the patient out-of-pocket expense were significantly higher for women who received LM than for
women who received OM. However, the operative time and blood loss during surgery were significantly less in women who received LM than in
women who received OM.
Conclusion: The overall expense is higher for LM than for OM; however, the laparoscopic approach has numerous advantages for patients,
including shorter operative time, less blood loss, and a more rapid recovery time. No difference existed in the rate of complications or in the
recurrence of disease for the two procedures.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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By the age of 35 years, as many as 40% of Caucasian women
will have uterine leiomyomas; by the age of 50 years, the inci-
dence rises to nearly 70% [1]. Approximately 34,000 myo-
mectomies are performed each year in the United States [2]. By
contrast, a survey in 2000by theDepartment ofHealth inTaiwan
indicated that 6734 myomectomies had been performed the
previous year [3]. Although asymptomatic patients with my-
omas can be followed with periodic ultrasound studies,
approximately one-fourth experience menorrhagia, lower
abdominal pain and distention, problems with micturition and
defecation, and infertility.When these symptoms do not respond
tomedical therapy, surgery is needed. Abdominal hysterectomy,
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http://dx.doi.org/10.1016/j.tjog.2013.04.013and uterine fibroid embolization (UFE) are among the most
common surgical procedures [4].
Myomectomy has traditionally been performed by open
laparotomy; however, LM has become an attractive option
because patients recovery more quickly and have less blood
loss during the procedure, and therefore less of a need for
blood transfusion. Laparoscopic myomectomy is less invasive,
produces less postoperative pain, and offers a shorter recovery
time, compared to OM [5e9]. In patients with large and
multiple myomas, LM has also been effective [10]. However,
the rate of complications or recurrence is the same with both
procedures.
Few studies have compared the costs of OM and LM. In
2001, Subramanian et al [11] retrospectively reviewed a
database of private insurance claims for 4394 women who had
myomectomies between 1995 and 1997. They reported that
OM was more expensive than LM ($8,860.00 vs. $8,018.00,
respectively) and patients had a longer hospital stay with OM
than with LM (2.91 days vs. 2.25 days, respectively); when
repeat procedures are required, an additional cost of $1264.00cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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myomectomy.
In Taiwan, LM has been performed for about 10 years. In
2007, coverage for the procedure was added to Taiwan’s
universal National Health Insurance (NHI) program.
To compare the total direct and indirect costs of LM and
OM, we designed a retrospective study involving Taiwanese
women who had undergone either of the procedures at a
university center. The initial costs may be higher for LM than
for OM; however, we theorized that this should be offset by
the shorter hospitalization time and speedier recovery offered
by the laparoscopic approach.
Methods
We retrospectively analyzed the clinical data of patients
who underwent traditional OM (n ¼ 74) and patients who
underwent LM (n ¼ 81) at a teaching hospital in the Kaoh-
siung County in southern Taiwan from June 1, 2004 to
October 31, 2007. All patients received preoperative ultra-
sound examinations for determining the size, type, and number
of myomas. This study was approved by the Institutional
Review Board of the E-Da Hospital (Taiwan, China), and each
patient gave written, informed consent.
The recorded data included patient demographic information
and clinical characteristics such as age; weight; type and size of
myoma; type of deliveries; number of pregnancies; menopausal
status; micturition difficulty; hypogastralgia; and menorrhagia;
and perioperative data, including the hemoglobin (Hb) level,
hematocrit (Hct), platelet (Plt) count, white blood cell (WBC)
count, blood loss and blood transfusions, surgical time, compli-
cations, postoperative drainage, and follow-up data (e.g., recur-
rence rate).
Surgeries were performed by one of six doctors at the hos-
pital. The author is the only trained laparoscopist and has more
than 10 years experience. All patients who were assessed by the
author received LMs. The other five doctors did not perform
LMs, and had 5e18 years experience in performingOMs.When
patients saw one of the five doctors, they received an OM. Pa-
tients randomly saw one of the six doctors previously described.
Indications formyomectomyweremenorrhagia, dysmenorrhea,
irregular menses, abdominal pain, abominal swelling, primary
infertility, and secondary infertility.
Open myomectomy was performed in a standard manner. In
brief, the surgeon made a Pfannenstiel incision or vertical inci-
sion in the abdomen. The myomas were removed with a com-
bined sharp and blunt dissection. The uteruswas sutured in layers
with 1-0 poliglecaprone 25 sutures (Monocryl Plus, Ethicon,
Kaohsiung County). The fascia and skin were then closed.
Laparoscopic myomectomy was performed as described by
Dubuisson et al [12]. In this procedure, a Verres needle was
inserted in the inferior portion of the umbilicus, and a CO2
pneumoperitoneum was created (pressure, 15 mmHg; gas flow
rate, 3e4 L/min). A small vertical or horizontal incision was
made on the lower edge of the umbilicus. A trocar sleeve and
trocar were inserted. A laparoscope was connected to a high-
resolution video monitoring system and the pelvic andabdominal organs were inspected. Laser, electrosurgical in-
struments, and/or forceps and scissors were used to remove the
uterine myomas. When a pedunculated myoma was noted,
scissors and bipolar knife were used to remove it. If a subserous
myoma or submucous myoma was noted, a wide horizontal
incision was made with unipolar above the myoma. Grasping
forceps were used to free the myoma from the normal uterine
muscle. A PlasmaKinetic bipolar knife (Gyrus, Minneapolis,
MN,USA)was used to control bleeding. Amorcellator was then
used to remove all myomatous material from the abdominal
cavity. The uterus was closed in layers with absorbable suture.
After the completion of the procedure, the instruments were
removed and the skin incisions were closed.
For the purpose of this analysis, the total medical services
expense is the total inclusive cost of the procedure and care;
the total NHI service expense is the costs paid for by the NHI;
and the total patient expense is the expenses that the patient
was responsible to pay.
Statistical analysis
In general, the continuous data were expressed as the
mean the standard deviation (SD), whereas the categorical data
were expressed as the number and percentage [n (%)] by group.
For the continuous data, differences between groups were
analyzed using a two-sample t test. For categorical data, differ-
ences between groups were analyzed by using the Pearson Chi-
square test. Furthermore, abnormal continuous variables were
expressed as themedianswith the interquartiles (i.e.,Q1eQ3) and
were comparedbyusing thenonparametricMann-WhitneyU test.
The medical expenses of distinct surgical types were
expressed as themean the SD, andwere compared by using the
Mann-Whitney U test because of the nonnormal distribution of
the data. In addition, univariate andmultivariate linear regression
models were used to identify the association ofmedical expenses
with the patients’ clinical characteristics. An estimated 95%
confidence interval (CI) for betawas shown for specific variables
in themodels. In addition, variableswith a statistical significance
of p< 0.2, observed from the univariate linear regressionmodel,
were selected and placed into the multivariate linear regression
analysis. The multivariate linear regression analysis was applied
after factoring in the multiple variables and adjusting for age. A
value of p < 0.05 was considered significant. All statistical an-
alyses were performed by using SPSS 15.0 statistics software
(SPSS Inc, Chicago, IL, USA).
Results
Table 1 summarizes the demographic and clinical charac-
teristics of the OM and LM groups. The mean age of the
patients in the OM group and the LM group was 40.08  6.49
years and 41.14  6.46 years, respectively. The mean patient
weight was significantly lower in the LM group
(56.47  7.63 kg) than in the OM group (61.79  11.5 kg).
The number of births and the frequency of micturition diffi-
culty and hypogastralgia differed significantly between the
two groups.
Table 1
Patient demographic and clinical characteristics.
Open
myomectomy
(n ¼ 74)
Laparoscopic
myomectomy
(n ¼ 81)
p
Age (y) 40.08  6.49 41.14  6.46 0.312
Weight (kg) 61.79  11.50 56.47  7.63 0.001*
Type of myoma
Single 55 (74.3%) 51 (63.0%) 0.178
Multiple 19 (25.7%) 30 (37.0%)
Size of myoma
 5 cm 13 (17.6%) 23 (28.4%) 0.110
>5 cm 61 (82.4%) 58 (71.6%)
Previous delivery
None 24 (32.4%) 24 (29.6%) 0.929
Vaginal 38 (51.4%) 43 (53.1%)
Cesarean 12 (16.2%) 14 (17.3%)
Pregnancy
Never 21 (28.4%) 17 (21.0%) 0.378
One or more times 53 (71.6%) 64 (79.0%)
Number births
0 or 1 31 (41.9%) 62 (76.5%) <0.001*
 2 43 (58.1%) 19 (23.5%)
Menopause (yes) 3 (4.1%) 2 (2.5%) 0.580
Micturition difficulty (yes) 2 (2.7%) 13 (16.0%) 0.004*
Hypogastralgia (yes) 40 (54.1%) 27 (33.3%) 0.009*
Menorrhagia (yes) 26 (35.1%) 32 (39.5%) 0.577
The data are presented as the mean  the standard deviation for continuous
variables and as number and percentage (%) for categorical variables.
The p is derived by two-sample t test for continuous variables and by Pearson’s
Chi-square or Fisher’s exact test for categorical variables.
*p < 0.05.
Table 2
Intraoperative and postoperative data.
Outcomes Open
myomectomy
(n ¼ 74)
Laparoscopic
myomectomy
(n ¼ 81)
p
Surgical time (min) 120 (90e146.3) 100 (73e120) 0.001*
Blood loss (mL) 150 (100e305) 100 (100e200) 0.011*
Received blood transfusion 13 (17.6%) 1 (1.2%) < 0.001*
Blood transfusion amount
(mL)
1000 (500e1000) 1000a e
Postoperative drainage 10 (13.5%) 15 (18.5%) 0.397
Amount of postoperative
drainage (mL)
337.5 (233e773.7) 210 (150e435) 0.233
Complications 20 (27.0%) 16 (19.8%) 0.284
Fever 19 (25.7%) 14 (17.3%) 0.202
Rehospitalization within
30 days after surgery
1 (1.4%) 0 (0%) 0.477
Recurrence 4 (5.4%) 2 (2.5%)b 0.426
Data are presented as the median with the interquartile range (IQR; Q1eQ3)
for continuous variables and as the number and percentage (%) for categorical
variables.
The p is derived by using the Mann-Whitney U test for continuous variables
and by using the Pearson’s Chi-square test for categorical variables.
Blood transfusion and postoperative drainage data are summarized only for
subjects who received blood transfusions or exhibited postoperative drainage.
*p < 0.05.
a Only one patient received a blood transfusion, thus there is no IQR to report
b Two subjects with recurrence in the laparoscopic myomectomy group un-
derwent a second surgery.
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data of the two groups. The median surgical time and blood
loss were significantly less in the LM group than in the OM
group (surgical time was 100 minutes [73e120 minutes] vs.
120 minutes [90e146 minutes], respectively; blood loss was
100 mL [100e200 mL] vs. 150 mL [100e305 mL], respec-
tively). Furthermore, the number of patients who received a
blood transfusion was significantly greater in the OM group
(n ¼ 13) than in the LM group (n ¼ 1). There was no dif-
ference between the groups in the number of patients with
postoperative drainage, complications, fever, rehospitalization
within 30 days after surgery, or recurrence.
Table 3 shows the total medical service expense, the total
NHI service expense, and the total patient out-of-pocket
expense. All were expressed in U.S. dollars (USD) ( $1.00
USD ¼ $30.03 New Taiwan dollars). The total medical service
expense averaged $1583.52 in the OM group and $1991.40 in
the LM group. The total NHI service expense averaged
$1239.12 in the OM group and $1295.05 in the LM group. The
total patient out-of-pocket expense averaged $344.40 in the
OM group and $696.35 in the LM group. The Mann-Whitney
U test showed that the patients who received LM may have
had a higher total expense, after tallying the total medical
expense ( p < 0.001), total NHI expense ( p < 0.003), and out-
of-pocket expense ( p < 0.001).
The medical resources for total NHI and patients’ own
expenses were further divided into 14 subcategories. Table 3
shows the comparison between the two groups. In regard tothe total NHI service expense, patients who received OM had
higher overall physicians’ consultation fees (OM, $54.99; LM,
$47.04; p < 0.001); ward fees (OM, $167; LM, $140.73;
p < 0.001); therapeutic management fees (OM, $12.93; LM,
$10.38; p ¼ 0.022), blood plasma fees (OM, $12.88; LM,
$0.96; p < 0.001), and medication fees (OM, $44.08; LM,
$26.19; p ¼ 0.01). However, patients who received LMs had
higher examination fees (OM, $127.49; LM, $155.98;
p ¼ 0.001) and surgical fees (OM, $521.66; LM, $581.7;
p ¼ 0.004). In regard to the patients’ own expenses, patients
who received LM had higher ward fees (OM, $135.65; LM,
$183.17; p ¼ 0.033), special material fees (e.g., laparoscopic
instruments or antiadhesions barrier) (OM, $132.35; LM,
$465.82; p < 0.001), and fees for other materials such as
gauze pads and tape (OM, $4.34; LM, $20.89; p <0.001).
However, patients who received OMs had higher anesthesia
fees (OM, $25.39; LM, $6.34; p ¼ 0.011), and injection fees
(OM, $29.7; LM, $6.78, p ¼ 0.009).
Based on a level of significance of p ¼ 0.2 for potential
factors that may affect the medical service expenses, the
univariate linear regression model showed that the total
medical service expense was associated with the type of sur-
gery, type of myoma, number of births, presence of hypo-
gastralgia, surgical time, need for blood transfusion, care for
postoperative drainage, and recurrence of myomas (Table 4).
The total NHI service expense was associated with surgical
time, blood transfusion, postoperative drainage, and presence
of fever. The patient’s total out-of-pocket expense was asso-
ciated with the type of surgery, patient’s age, type of myoma,
Table 3
Comparison of the medical expenses of traditional abdominal myomectomy
and laparoscopic myomectomy (N ¼ 155).
Medical expense
(USD)a
Open
myomectomy
(n ¼ 74)
Laparoscopic
myomectomy
(n ¼ 81)
pb
Total medical service
expense
$1583.52  $594.67 $1991.4  $606.16 <0.001*
Total NHI service
expense
$1239.12  $392.66 $1295.05  $392.43 0.003*
Physician
consultation
fees
$54.99  $19.06 $47.04  $25.34 < 0.001*
Ward fees $167  $54.96 $140.73  $84.45 < 0.001*
Examination fees $127.49  $68.85 $155.98  $73.18 0.001*
Radiological
procedure
fees
$12.65  $44.02 $11.31  $30.83 0.192
Therapeutic
management
fees
$12.93  $9.15 $10.38  $5.31 0.022*
Surgery fees $521.66  $140.82 $581.7  $202.55 0.004*
Blood plasma fees $12.88  $27.69 $0.96  $8.66 < 0.001*
Anesthesia fees $256.58  $70.42 $249.81  $74.67 0.999
Special material fees $12.55  $31.73 $55.95  $77.07 0.148
Medication fees $44.08  $104.05 $26.19  $30.92 0.010*
Pharmacy service
fees
$13.38  $4.53 $12.12  $6.33 < 0.001*
Injection fees $2.92  $1.56 $2.88  $3.46 0.062
Others NA NA e
Agency fees NA NA e
Total patient own
expense
$344.4  $373.57 $696.35  $381.71 < 0.001*
Physician’s
consultation
fees
NA $0.22  $1.98 0.339
Ward fees $135.65  $254.55 $183.17  $202.45 0.033*
Examination fees NA NA e
Radiological
procedure
fees
NA NA e
Therapeutic
management
fees
$2.48  $21.29 $0.18  $1.63 0.942
Surgery fees $12.38  $46.28 $10.28  $41.17 0.866
Blood plasma fees NA NA e
Anesthesia fees $25.39  $61.75 $6.34  $41.73 0.011*
Special material fees $132.35  $149.98 $465.82  $186.56 < 0.001*
Medication fees $1.36  $7.36 $1.2  $6.27 0.992
Pharmacy service
fees
NA NA e
Injection fees $29.7  $67.97 $6.78  $34.8 0.009*
Others $4.34  $4.46 $20.89  $111.81 < 0.001*
Agency fees $0.77  $2.68 $1.47  $4.54 0.280
USD ¼ U.S. dollars ($1.00 USD ¼ $30.03 New Taiwan dollars).
*Indicates a significant difference between groups, p < 0.05.
a Data are presented as the mean  the standard deviation
b The p is obtained by using the Mann-Whitney U test.
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recurrence ( p < 0.2 for all).
Variables with a statistical significance of p < 0.2 in the
univariate linear regression model were selected and placed
into the multivariate linear regression analysis. The multivar-
iate linear regressiondcontrolled for patient agedrevealedthat the average total medical service expense was signifi-
cantly associated with surgical type, surgical time, need for
blood transfusion, and recurrence of the disease (Table 5). In
patients who received LM, the total medical service expense
was increased by 528.78 (95% CI 329.03-728.52, p < 0.001);
surgical time, by 3.01 (95% CI 0.79-5.23, p ¼ 0.008);
requirement for blood transfusion, by 738.05 (95% CI 411.39-
1064.72, p < 0.001), and recurrence, by 738.05 (95% CI
287.6-1270.96, p ¼ 0.002). For patients who received LM,
multivariate linear regression analysis similarly showed that
the total NHI service expense was significantly increased by
142.44 (95% CI 27.23-257.64; p ¼ 0.016); surgical time, by
2.14 (95% CI 0.71-3.56, p ¼ 0.004), and requirement for
blood transfusion, by 456.28 (95%CI 248.02-664.53;
p < 0.001). However, in patients who received LM, the total
patient’s own expense was only significantly increased by
$357.99 (95% CI 142.73-573.25; p ¼ 0.001) and for patients
with recurrence, by 700.58 (95% CI 150.46-1250.7;
p ¼ 0.013).
Discussion
This study compared the costs of OM and LM at a teaching
hospital in southern Taiwan. The total medical service expense
was significantly higher for patients who received LM than for
patients who received OM ($1991.40 vs. $1583.52,
respectively).
Many studies have compared the costs of hysterectomy and
myomectomy for the treatment of uterine myomas [13e15].
However, few studies exist that compare the cost of OM with
the cost of LM. In 2001, Subramanian et al [11] analyzed the
outcomes and the use of resources associated with myomec-
tomy and found that abdominal myomectomy (n ¼ 1400) was
more expensive than laparoscopic myomectomy (n ¼ 24)
($8860.00 vs. $8018.00, respectively) and patients had a
longer hospital stay with abdominal myomectomy than with
laparoscopic myomectomy (2.91 days vs. 2.25 days, respec-
tively). Stringer et al [16] report that OM is more expensive
than LM and that LM is associated with a longer operating
time than OM. These conclusions are different than the con-
clusions of the current study. In the study by Stringer et al, the
hospital stay was longer and the wound was larger and
required a greater use of analgesics; thus, the charges in the
OM group were higher for room, board, pharmacy, and labo-
ratory studies. However, the charges for the operating room
time and instrumentation were higher for LM. In the United
States, the hospital room charge is very high so that a longer
hospital stay results in a much greater total expense. In
Taiwan, the NHI pays the charges for room, board, pharmacy,
laboratory and radiology. The NHI pays a fixed fee for the
operating room time. From 2004 to 2007, the NHI did not
cover instruments; therefore, the greatest expense during that
period was for instruments.
In our study, we found that the total patient out-of-pocket
expense was higher in the laparoscopy group than in the lap-
arotomy group. Laparoscopic myomectomy required less time
than OM; however, laparoscopic surgery is more costly
Table 4
Univariate linear regression of the association of medical service expenses in regard to the surgical type and patient clinical characteristics (N ¼ 155).
Total medical service expense Total NHI service expense Total patient own expense
b (95% CI) p b (95% CI) p b (95% CI) p
Surgical type (LM vs. OM) 404.21 (215.09, 593.33) < 0.001* 55.43 (68.15, 179.01) 0.377 348.78 (229.82, 467.74) < 0.001*
Age (yr) 5.96 (9.48, 21.4) 0.447 1.21 (10.8, 8.38) 0.804 7.17 (2.94, 17.28) 0.163*
Type of myoma
(multiple vs. single)
152.16 (64.24, 368.55) 0.167* 50.86 (84.55, 186.28) 0.459 101.29 (39.97, 242.55) 0.159*
Size of myoma
( > 5 cm vs.  5 cm )
92.23 (143.69, 328.15) 0.441 77.6 (68.43, 223.63) 0.295 14.63 (140.73, 169.99) 0.853
Type of delivery
Vaginal vs. none 107.24 (333.7, 119.22) 0.351 89.48 (229.5, 50.55) 0.209 17.77 (167, 131.47) 0.814
Cesarean vs. none 58.32 (361.05, 244.42) 0.704 26.61 (213.79, 160.58) 0.779 31.71 (231.2, 167.79) 0.754
Pregnancy
1 vs. none 30.08 (262.06, 201.9) 0.798 67.48 (210.94, 75.98) 0.354 37.4 (115, 189.8) 0.628
Number of births
2 vs. 1 207.46 (408.49, 6.42) 0.043* 21.46 (104.82, 147.73) 0.738 229.01 (357.75, 100.08) 0.001*
Menopause 277.8 (840.99, 285.39) 0.331 40.61 (390.82, 309.59) 0.819 237.18 (606.59, 132.22) 0.207
Micturition difficulty 212.57 (123.33, 548.48) 0.213 0.29 (209.03, 209.61) 0.998 212.28 (7.03, 431.59) 0.058*
Hypogastralgia 261.81 (458.91, 64.71) 0.010* 77.02 (201.33, 47.3) 0.223 184.8 (313.91, 55.69) 0.005*
Menorrhagia 88.9 (116.88, 294.68) 0.395 68.45 (58.97, 195.86) 0.290 20.46 (115.08, 156) 0.766
Surgical time (min) 4.26 (2.04, 6.48) < 0.001* 3.29 (1.95, 4.63) < 0.001* 0.97 (0.55, 2.49) 0.210
Blood loss (mL) 35.76 (235.41, 163.89) 0.724 47.43 (76.17, 171.04) 0.450 83.19 (213.8, 47.43) 0.210
Received blood transfusion 590.89 (253.42, 928.36) 0.001* 520.67 (320.52, 720.81) <.001* 70.23 (159.63, 300.08) 0.547
Postoperative drainage 365.17 (100.13, 630.21) 0.007* 309.14 (148.29, 470) < 0.001* 56.03 (122.13, 234.19) 0.535
Complications 110.54 (336.15, 15.07) 0.335 20.91 (161.17, 119.36) 0.769 89.64 (237.7, 58.42) 0.234
Fever 107.38 (135.85, 350.61) 0.384 122.14 (27.77, 272.06) 0.110* 14.77 (175.02, 145.49) 0.856
Recurrence 505.26 (5.85, 1016.37) 0.053* 43.34 (277.4, 364.09) 0.790 461.92 (129.9, 793.94) 0.007*
Abbreviations: OM, open myomectomy (n ¼ 74); LM, laparoscopicmyomectomy (n ¼ 81); NHI, National Health Insurance.
The data show the estimated b and the 95% confidence interval (CI) for b. Specific variables in models are shown.
*p < 0.02.
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reusable. Special material fees include fees for antiadhesive
materials (which were not used in all patients), hemostatic
forceps, and hemostatic cotton. In LM, some special in-
struments and aspiration devices are also required. Of course,
there are factors other than cost to consider. In our study, the
median blood loss and surgical time were less in the LM group
than in the OM group, and the number of patients who
required blood transfusions was significantly higher in the OMTable 5
Multivariate linear regression of the association of medical service expenses with s
Total medical service expense
b (95% CI) p b (95
Surgical type (LM vs. OM) 528.78 (329.03, 728.52) < 0.001* 142.4
Age (y) 5.65 (9.1, 20.41) 0.450 2.3
Type of myoma
(multiple vs. single)
32.32 (161.21, 225.85) 0.742 e
Number of births
 2 vs.  1 7.76 (188.09, 203.61) 0.938 e
Micturition difficulty e e
Hypogastralgia 73.98 (260.03, 111.97) 0.433 e
Surgical time (min) 3.01 (0.79, 5.23) 0.008* 2.1
Received blood transfusion 738.05 (411.39, 1064.72) <0.001* 456.2
Postoperative drainage 45.06 (212.68, 302.79) 0.730 114.3
Fever e 74.8
Recurrence 779.28 (287.6, 1270.96) 0.002* e
LM ¼ laparoscopic myomectomy; NHI ¼ National Health Insurance; OM ¼ open
The data show the estimated b and the 95% confidence interval for b. Specific va
The total patient number is 155 with 81 patients in the LM group and 74 patients
*p < 0.05.group. Multivariate analysis indicated that LM was associated
with a shorter surgical time and less blood loss.
Many reports have confirmed the advantages of LM such as
rapid postoperative recovery, a shorter hospital stay, less
postoperative pain, and greater patient satisfaction.[5,7,9,17]
However, LM requires a longer surgical time, compared to
OM [10]. In a meta-analysis of randomized controlled trials of
LM versus OM, Jin et al [5] found that LM was associated
with a longer operation time, but reduced operative blood loss.urgical type and with patient clinical characteristics (adjusted for patient age).
Total NHI service expense Total patients own expense
% CI) p b (95% CI) p
4 (27.23, 257.64) 0.016* 357.99 (142.73, 573.25) 0.001*
1 (6.31, 10.93) 0.597 1.21 (17.46, 15.04) 0.883
63.66 (151.48, 278.79) 0.560
10.82 (231.95, 210.3) 0.923
95.76 (236.19, 42.77) 0.569
136.02 (344.68, 72.64) 0.200
4 (0.71, 3.56) 0.004* e
8 (248.02, 664.53) < 0.001* e
7 (47.31, 276.05) 0.164 e
5 (58.62, 208.32) 0.270 e
e 700.58 (150.46, 1250.7) 0.013*
myomectomy.
riables in models are shown.
in the OM group.
232 C.-C. Chang / Taiwanese Journal of Obstetrics & Gynecology 52 (2013) 227e232Other authors have noted comparable surgical times between
LM and OM. Paul et al [9] reviewed a single surgeon’s
experience with LMs during a 16-year period, and found that
the procedure was comparable to OM with respect to the
duration of surgery, blood loss, and complication rate. With
OM, a greater amount of time is required to suture the large
abdominal wound, compared to the time required to close the
3 or 4 small incisions in LM.
Recent studies have indicated that LM and OM have
similar or low complication rates [5,8]. In our study, we found
that OM and LM had similar complication rates (27% vs.
19.8%, respectively), which is consistent with the results of
previous studies. In addition, the recurrence rate between the
two groups (5.4% [OM] vs. 2.5% [LM]) was not different; this
is also similar to previous reports [18].
In Taiwan before 2007, the NHI did not pay for LM because
performing LM requires advanced training and the surgeon’s
skill is critical and because only a few well-trained surgeons
were able and willing to perform LM in that period. Most sur-
geons still prefer performing OM. After 2007, the NHI began
paying for LM and thus the medical expense was no longer a
concern. More surgeons were willing to be trained to perform
LM because of its effectiveness, shorter hospital stay, less
wound pain, and faster recovery than OM. As a surgeon gains
experience in performing LM, the operative time should
shorten, and thus it should become more popular in Taiwan.
There are some limitations to this study such as its retro-
spective nature and the fact that the study data are limited to a
single institution. The follow-up periodwas relatively short, and
pregnancy data were not analyzed. Therefore, no conclusions
can be made about fertility after the two procedures. Theweight
of the fibroid tissue was not examined or compared between the
groups. However, the weight of the fibroid tissue will not alter
the difficulty of the surgery and is not necessarily correlatedwith
the myoma size. Data were included from only one experienced
laparoscopic surgeon, whereas data from five surgeons experi-
enced in performing OM were included. In essence, this study
compared one well-trained, experienced laparoscopist with
well-trained surgeons who were experienced in performing
open myomectomy. This should not have affected the results;
however, studies with data from other well-trained laparoscopic
surgeons would have been desirable to assist in confirming the
results. In addition, studies would be useful that compare data
from surgeons who are experienced in performing both LM and
OM. We did not calculate values such as the cost-performance
ratio or the cost value.
In conclusion, the overall cost is higher for laparoscopic
myomectomy than for traditional open myomectomy. Forpatients, however, the laparoscopic approach has numerous
advantages such as a shorter operative time, less blood loss,
and a more rapid recovery time. The complication rate and
recurrence rate were the same for both procedures.
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